Cogent Insider Sells $2.5 Million in Stock Amid Staggering 300% Price Surge [Yahoo! Finance]
Cogent Biosciences, Inc. (COGT)
Last cogent biosciences, inc. earnings: 11/8 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.cogint.com/investor-relations
Company Research
Source: Yahoo! Finance
This sale represented 37.27% of Evan Kearns's direct holdings, as reported, reducing direct ownership to 109,398 shares. No indirect holdings or derivative transactions were involved; all shares were disposed of from direct ownership. These 10 stocks could mint the next wave of millionaires › Evan Kearns, the chief legal officer at Cogent Biosciences (NASDAQ:COGT) , reported an open-market sale of 65,000 shares for a transaction value of $2.52 million, according to a Dec. 30 SEC Form 4 filing Metric Value Shares sold (direct) Transaction value $2.5 million Post-transaction shares (direct) Post-transaction value (direct ownership) $4.25 million Transaction value based on SEC Form 4 weighted average purchase price ($38.70); post-transaction value based on Dec. 26 market close price used in SEC calculations. How significant was the reduction in Evan Kearns's holdings as a result of this transaction? The sale reduced Kearns's direct ownership by 37.27%, leavin
Show less
Read more
Impact Snapshot
Event Time:
COGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COGT alerts
High impacting Cogent Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
COGT
News
- Cogent Biosciences Announces Anticipated 2026 Commercial and Clinical Milestones for Bezuclastinib and Precision Therapies PortfolioGlobeNewswire
- H.C. Wainwright is Bullish on Cogent Biosciences, Inc. (COGT) [Yahoo! Finance]Yahoo! Finance
- Cogent Biosciences (NASDAQ:COGT) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.MarketBeat
- Cogent Biosciences Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Cogent Biosciences Announces Presentation at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
COGT
Sec Filings
- 1/5/26 - Form 4
- 12/30/25 - Form 4
- 12/30/25 - Form 4
- COGT's page on the SEC website